Pharmacy Articles on MDLinx

Articles

Article Summary

Time-dependent inhibition of CYP3A4 and CYP2C9 by noscapine potentially explains clinical noscapine–warfarin interaction
British Journal of Clinical Pharmacology, 01/26/2010

Fang ZZ et al. – TDI of CYP3A4 and CYP2C9 by noscapine potentially explains clinical noscapine–warfarin interaction.

Read this article in British Journal of Clinical Pharmacology read MDlinx article: Time-dependent inhibition of CYP3A4 and CYP2C9 by noscapine potentially explains clinical noscapine–warfarin interaction

<< Previous Article |
Showing Latest Articles

Your Unread Messages in Pharmacy


Most Popular Pharmacy Articles

Last month's top read Top 50 of 2009

1 New erectile dysfunction treatment STAXYN approved in the U.S. BayNews International, June 28, 2010    Free full text

2 Ginkgo biloba and risk of cancer: secondary analysis of the Ginkgo Evaluation of Memory (GEM) Study Pharmacoepidemiology and Drug Safety, June 3, 2010

3 Effect of high-dose cranberry juice on the pharmacodynamics of warfarin in patients British Journal of Clinical Pharmacology, June 17, 2010

4 Aspirin for Acute Coronary Syndromes: Have We Learned the Correct Dose Yet Current Cardiology Reports, June 1, 2010

5 New osteoporosis treatment approved for postmenopausal women American Pharmacists Association, June 14, 2010    Free full text

6 A Risk-Benefit Assessment of Paracetamol (Acetaminophen) Combined with Caffeine Pain Medicine, June 10, 2010

7 Withdrawal symptoms after gabapentin discontinuation American Journal of Health-System Pharmacy, June 8, 2010
Exclusive Author Commentary

8 Aspirin for primary prevention: yes or no? Journal of Primary Health Care, June 17, 2010    Free full text

9 Rationale for targeted therapies and potential role of pazopanib in advanced renal cell carcinoma Biologics: targets & therapy, June 29, 2010    Free full text

10 Antihypertensive Effects of Aspirin: What is the Evidence Current Hypertension Reports, June 11, 2010

11 Intravenous Voriconazole after Toxic Oral Administration Antimicrobial Agents and Chemotherapy, June 3, 2010

12 Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study The Lancet - Early Online Publication, June 3, 2010

13 New therapies for asthma: is there any progress? Trends in Pharmacological Sciences, June 4, 2010

14 Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas Cancer Chemotherapy and Pharmacology, June 2, 2010

15 Oral Aloe vera as a treatment for osteoarthritis British Journal of Community Nursing, June 4, 2010

16 Saxagliptin: New Therapy for Type 2 Diabetes Journal of Pharmacy Technology, June 11, 2010

17 Post-marketing Surveillance of Methadone and Buprenorphine in the United States Pain Medicine, June 25, 2010

18 Update on Anticonvulsant Drugs Current Neurology and Neuroscience Reports, June 2, 2010

19 Medicinal plants used by traditional medicine practitioners for the treatment of HIV/AIDS and related conditions in Uganda Journal of Ethnopharmacology , June 25, 2010

20 Milnacipran: A New Treatment for Fibromyalgia Syndrome Journal of Pharmacy Technology, June 7, 2010

Indexed Journals in Pharmacy: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacistmore

Other Topics in Pharmacy

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Media Tool Newsletter Icon
Newsletter

Media Tool Newsletter Icon
RSS

Media Tool Newsletter Icon
Follow Us

Media Tool Facebook Icon
Facebook

  • Media Tool Newsletter Icon
    Newsletter

  • Media Tool Newsletter Icon
    RSS

  • Media Tool Newsletter Icon
    Follow Us

  • Media Tool Newsletter Icon
    Facebook

  • Receive free subspecialty
    "5-minute updates" via email

    Sign up!

    Send the E-mail Newsletter to a Colleague


    Send

    Close

    Subscribe to our free RSS feeds:
    Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

    Close

    Follow Us on Twitter
    Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

    Close